CNTX

Context Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 4/10
  • Value↓ 4/10
Context Therapeutics sales and earnings growth
CNTX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 73.63%
  • FCF Y/Y↓ -32.57%
Context Therapeutics gross and profit margin trends
CNTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 1216.05%
Context Therapeutics net debt vs free cash flow
CNTX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Context Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗